ClinicalTrials.Veeva

Menu

INvestigating SIGnificant Health TrendS in the Management of Superficial Vein Thrombosis (INSIGHTS-SVT)

G

GWT-TUD

Status

Completed

Conditions

Superficial Vein Thrombosis

Treatments

Drug: any drug
Procedure: any procedure/surgery
Other: Any non-pharmacological treatment of SVT

Study type

Observational

Funder types

Other

Identifiers

NCT02699151
INSIGHTS-SVT

Details and patient eligibility

About

Superficial vein thrombosis (SVT) and venous thromboembolism (VTE) are related entities. Only in the last years a series of observational studies mainly conducted in France could show that ´isolated SVT´ (without concomitant deep vein thrombosis and/or pulmonary embolism) is in fact not a benign and spontaneously healing disease but bears a potential for severe thromboembolic complications once not treated adequately. INSIGHTS-SVT study aims at collecting representative data on the current management and outcomes of SVT in Germany under real-life conditions. It will document the implementation of the recently issued national SVT guidelines issued by the Society for Angiology (DGA) and the Society for Phlebology (DGP).

Enrollment

1,210 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Confirmed, acute, isolated SVT of the lower extremities
  • written informed consent

Exclusion criteria

  • SVT located at ≤ 3 cm of the saphenofemoral crossing (as such patients need to be treated for DVT)
  • Subjects unlikely to comply with the requirements of the protocol (due to cognitive and/or language limitations)
  • Patient(likely) not available for 1-year documentation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems